デフォルト表紙
市場調査レポート
商品コード
1474850

静脈内注入装置の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2024年~2030年

Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Type (Manual IO Needles, Battery Powered Driver), By End-use (Hospitals and Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 110 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
静脈内注入装置の市場規模、シェア、動向分析レポート:タイプ別、最終用途別、地域別、セグメント予測、2024年~2030年
出版日: 2024年04月02日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内注入装置市場の成長と動向:

Grand View Research, Incの最新レポートによると、世界の静脈内注入装置市場規模は2030年までに14億100万米ドルに達し、2024~2030年のCAGRは6.2%で成長すると予測されています。

同市場は、血管系に直接薬剤や輸液を迅速に投与する需要の増加、手術件数の急増、技術的に高度な腹腔内注入装置の開発などが成長の原動力となっています。加えて、外傷関連発作や心臓発作などの緊急症例の増加が、予測期間中の市場成長をさらに促進すると予想されます。

遠位・近位脛骨、胸骨、遠位大腿骨、踵骨など、骨内注入の挿入部位は多数あります。胸骨に緊急薬液を投与する確実かつ迅速な手段の1つは、血管アクセスが容易な胸骨骨内注入です。

例えば、WHOによると、心血管疾患は世界中で毎年1,790万人の死亡原因となっています。また、心血管疾患による死亡の5人に4人は脳卒中と心臓発作によるもので、これらの死亡の約30%は70歳以下の人口で発生しています。

先進的な骨内注入装置の発売は、予測期間中の市場成長を後押しすると予測されます。例えば、2023年6月、Teleflex Incorporatedは、MR条件付き表示用のArrow EZ-1O IO針について米国FDAの510(k)認可を取得しました。EZ-IO針は、Arrow EZ-IO静脈アクセスシステムの重要なコンポーネントです。EZ-1Oは、正確、迅速、安定した挿入を可能にするダイヤモンドチップを備えています。

骨内注入装置市場レポートハイライト

  • タイプ別では、手動IO針セグメントが2023年に49.4%の最大収益シェアで市場をリードしています。最も一般的に使用されている手動IO針は、Cardinal Health Illinois/Jamishidi needle、Cook critical care sur-fast needle、Cook Dieckman modified needleです。
  • 最終用途別のと、病院・クリニックセグメントは2023年に54.9%の最大収益シェアで市場をリードしました。病院・クリニックセグメントは、整備された最新のインフラが利用可能であること、洗練された医療インフラを開発するための投資が増加していること、熟練した専門家の数が増加していることなどが牽引しています。
  • 北米は2023年の売上高シェア41.33%で市場を独占しました。同地域の先進医療インフラ、先進治療に対する意識の高まり、高齢化人口の増加が同市場の優位性に寄与しています。
  • アジア太平洋は、特に中国やインドなどの新興国において、近年医療インフラへの投資が増加していることから、推定・予測期間中に最も速いCAGRで成長するとみられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場ドライバー分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • PESTLE分析
    • ポーターのファイブフォース分析

第4章 静脈内注入装置市場-セグメント分析、タイプ別、2018~2030年(100万米ドル)

  • 静脈内注入装置市場:タイプダッシュボード
  • 静脈内注入装置市場:タイプ変動分析
  • 静脈内注入装置市場規模と動向分析、タイプ別、2018~2030年
  • 手動IO針
    • 手動IO針市場推定・予測、2018~2030年
  • バッテリー駆動ドライバー
    • バッテリー駆動ドライバー市場推定・予測、2018~2030年
  • 衝撃駆動装置
    • インパクト駆動型装置市場推定・予測、2018~2030年

第5章 静脈内注入装置市場-セグメント分析、最終用途別、2018~2030年(100万米ドル)

  • 静脈内注入装置市場:最終用途ダッシュボード
  • 静脈内注入装置市場:最終用途変動分析
  • 静脈内注入装置市場規模と動向分析、最終用途別、2018~2030年
  • 病院・クリニック
  • 外来手術センター
  • その他

第6章 国別、タイプ別、最終用途別の地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測と動向分析、2018~2030年
  • 北米
    • 北米の静脈内注入装置市場推定・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の静脈内注入装置市場推定・予測、2018~2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の静脈内注入装置市場推定・予測、2018~2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの静脈内注入装置市場推定・予測、2018~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの静脈内注入装置市場推定・予測、2018~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業分類
  • 戦略マッピング
    • 取得
    • コラボレーション
    • 新しいプラットフォームの立ち上げ
    • その他
  • 企業プロファイル/上場企業
    • Aero Healthcare AU Pty Ltd
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • BIOPSYBELL SRL
    • Cook Group
    • 南米 Medical
    • Argon Medical Devices, Inc.
    • Cardinal Health, Inc.
    • Medax SRL Unipersonle
    • StarFish Medical
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America Intraosseous Infusion Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 4. North America Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 5. North America Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 6. U.S. Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 7. U.S. Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 8. Canada Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 9. Canada Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10. Europe Intraosseous Infusion Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 11. Europe Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. Europe Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13. Germany Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 14. Germany Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 15. UK Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 16. UK Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17. France Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 18. France Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 19. Italy Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 20. Italy Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 21. Spain Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Spain Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23. Denmark Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 24. Denmark Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 25. Sweden Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 26. Sweden Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 27. Norway Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 28. Norway Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29. Asia Pacific Intraosseous Infusion Devices Market, by Country, (USD Million 2018 - 2030
  • Table 30. Asia Pacific Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Asia Pacific Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32. China Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 33. China Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34. Japan Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 35. Japan Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 36. India Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 37. India Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38. South Korea Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 39. South Korea Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 40. Australia Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 41. Australia Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42. Thailand Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Thailand Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44. Latin America Intraosseous Infusion Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 45. Latin America Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Latin America Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47. Brazil Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. Brazil Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 49. Mexico Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 50. Mexico Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 51. Argentina Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 52. Argentina Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 53. MEA Intraosseous Infusion Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 54. MEA Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 55. MEA Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 56. South Africa Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 57. South Africa Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58. Saudi Arabia Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 59. Saudi Arabia Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60. UAE Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 61. UAE Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 62. Kuwait Intraosseous Infusion Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 63. Kuwait Intraosseous Infusion Devices Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Intraosseous infusion devices market segmentation
  • Fig. 7 Market snapshot, 2023
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Market trends & outlook
  • Fig. 11 Market driver relevance analysis (current & future impact)
  • Fig. 12 Market restraint relevance analysis (current & future impact)
  • Fig. 13 PESTLE analysis
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Intraosseous infusion devices market: type outlook and key takeaways
  • Fig. 16 Intraosseous infusion devices market: type movement analysis
  • Fig. 17 Manual IO needles market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 18 Battery powered driver market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 19 Impact driven devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 20 Intraosseous infusion devices market: End-use outlook and key takeaways
  • Fig. 21 Intraosseous infusion devices market: End-use movement analysis
  • Fig. 22 Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 23 Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • Fig. 25 Intraosseous infusion devices market: region movement analysis
  • Fig. 26 North America Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. country dynamics
  • Fig. 28 U.S. Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada country dynamics
  • Fig. 30 Canada Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany country dynamics
  • Fig. 33 Germany Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 34 UK country dynamics
  • Fig. 35 UK Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden country dynamics
  • Fig. 43 Sweden Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway country dynamics
  • Fig. 45 Norway Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico country dynamics
  • Fig. 65 Mexico Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina country dynamics
  • Fig. 67 Argentina Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa country dynamics
  • Fig. 70 South Africa Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia country dynamics
  • Fig. 72 Saudi Arabia Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE country dynamics
  • Fig. 74 UAE Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait country dynamics
  • Fig. 76 Kuwait Intraosseous infusion devices market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Strategy mapping
  • Fig. 79 Company market position analysis
目次
Product Code: GVR-4-68040-245-1

Intraosseous Infusion Devices Market Growth & Trends:

The global intraosseous infusion devices market size is expected to reach USD 1,401.0 million by 2030 and is projected to grow at a CAGR of 6.2% from 2024 to 2030, according to new report by Grand View Research, Inc. The market experiences growth driven by rise in demand for rapid administration of medications or fluids directly into vascular system, surge in number of surgeries, and development of technologically advanced intraosseous infusion devices. In addition, rise in number of emergency cases such as trauma-related attacks and heart attacks is further expected to fuel market growth during the forecast period.

There are numerous sites of intraosseous infusion insertion available such as distal & proximal tibia, sternum, distal femur, and calcaneum. One of the reliable and fastest means of administrating the emergency medication fluids in the sternum is the sternal intraosseous infusion which allow easy vascular access.

Increase in prevalence of cardiovascular diseases, surge in patient and physician awareness of newly launched treatment procedures, significant investments made by government in advanced technologies adopted for rapid and easy administration of medications, fluids or blood products.For instance, According to WHO, cardiovascular diseases cause 17.9 million deaths every year across the globe. In addition, 4 out of 5 cardiovascular disease deaths are caused due to strokes and heart attacks, and around 30% of these deaths occur in the population under 70 years of age.

Launch of advanced intraosseous infusion devices is estimated to boost the market growth during the forecast period. For instance, in June 2023, Teleflex Incorporated received 510(k) U.S. FDA clearance for Arrow EZ-1O IO needle for MR conditional labelling. The EZ-IO needle is a critical component of Arrow EZ-IO intraosseous vascular access system. EZ-1O has a diamond tip for precise, fast, and steady insertion.

Intraosseous Infusion Devices Market Report Highlights:

  • Based on type, the manual IO needles segment led the market with the largest revenue share of 49.4% in 2023. Most generally used manual IO needles are Cardinal Health Illinois /Jamishidi needle, and Cook critical care sur-fast needle, and Cook Dieckman modified needle
  • Based on end use, the hospitals & clinics segment led the market with the largest revenue share of 54.9% in 2023. The hospitals & clinics segment is driven by the availability of developed & latest infrastructure, rise in investments to develop sophisticated healthcare infrastructure, and increase in the number of skilled professionals
  • North America dominated the market with a revenue share of 41.33% in 2023. The region's advanced healthcare infrastructure, rise in awareness about advanced treatment, and a growing aging population contribute to the market's dominance
  • Asia Pacific is estimated to grow at the fastest CAGR during the forecast period, due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
      • 1.1.1.1. Type Segment
      • 1.1.1.2. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Rising number of emergency care cases
      • 3.2.1.3. Surge in technologically advanced product approvals and launches
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Restriction for the patient suffering from osteoporosis
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTLE Analysis
    • 3.3.2. Porter's Five Forces Analysis

Chapter 4. Intraosseous Infusion Devices Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 4.1. Intraosseous Infusion Devices Market: Type Dashboard
  • 4.2. Intraosseous Infusion Devices Market: Type Movement Analysis
  • 4.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Manual IO Needles
    • 4.4.1. Manual IO Needles Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.5. Battery Powered Driver
    • 4.5.1. Battery Powered Driver Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 4.6. Impact Driven Devices
    • 4.6.1. Impact Driven Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Intraosseous Infusion Devices Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

  • 5.1. Intraosseous Infusion Devices Market: End-use Dashboard
  • 5.2. Intraosseous Infusion Devices Market: End-use Movement Analysis
  • 5.3. Intraosseous Infusion Devices Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals and Clinics
    • 5.4.1. Hospitals and Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Regional Estimates & Trend Analysis by Country, Type, and End-use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Competitive Scenario
    • 6.3.3. Canada
      • 6.3.3.1. Canada Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Competitive Scenario
  • 6.4. Europe
    • 6.4.1. Europe Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Competitive Scenario
    • 6.4.3. UK
      • 6.4.3.1. UK Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Competitive Scenario
    • 6.4.4. France
      • 6.4.4.1. France Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Competitive Scenario
    • 6.4.5. Italy
      • 6.4.5.1. Italy Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Competitive Scenario
    • 6.4.6. Spain
      • 6.4.6.1. Spain Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Competitive Scenario
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Competitive Scenario
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.8.2. Key Country Dynamics
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Competitive Scenario
    • 6.4.9. Norway
      • 6.4.9.1. Norway Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.4.9.2. Key Country Dynamics
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Competitive Scenario
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Competitive Scenario
    • 6.5.3. China
      • 6.5.3.1. China Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Competitive Scenario
    • 6.5.4. India
      • 6.5.4.1. India Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Competitive Scenario
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.5.2. Key Country Dynamics
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Competitive Scenario
    • 6.5.6. Australia
      • 6.5.6.1. Australia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.6.2. Key Country Dynamics
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Competitive Scenario
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.5.7.2. Key Country Dynamics
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Competitive Scenario
  • 6.6. Latin America
    • 6.6.1. Latin America Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Competitive Scenario
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Competitive Scenario
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Competitive Scenario
  • 6.7. MEA
    • 6.7.1. MEA Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Competitive Scenario
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Competitive Scenario
    • 6.7.4. UAE
      • 6.7.4.1. UAE Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Competitive Scenario
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Intraosseous Infusion Devices Market Estimates and Forecasts, 2018 to 2030 (USD Million)
      • 6.7.5.2. Key Country Dynamics
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Acquisition
    • 7.2.2. Collaborations
    • 7.2.3. New Platform Launches
    • 7.2.4. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. Aero Healthcare AU Pty Ltd
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Platform Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Teleflex Incorporated
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Platform Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Becton, Dickinson and Company
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Platform Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. BIOPSYBELL S.R.L.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Platform Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Cook Group
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Platform Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. SAM Medical
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Platform Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Argon Medical Devices, Inc.
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Platform Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Cardinal Health, Inc.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Platform Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Medax SRL Unipersonle
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Platform Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. StarFish Medical
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Platform Benchmarking
      • 7.3.10.4. Strategic Initiatives